e-Therapeutics plc reported consolidated earnings results for the year ended January 31, 2018. For the period, on consolidated basis, the company’s operating loss was £6,768,000 against £16,330,000 a year ago. Loss before tax was £6,719,000 against £16,198,000 a year ago. Loss for the year attributable to equity holders of the Company was £5,359,000 against £13,125,000 a year ago. Loss per share - basic and diluted was 2.00 pence against 4.91 pence a year ago. Net cash from operating activities was £4,405,000 against £9,436,000 a year ago. Acquisition of property, plant and equipment was £66,000 against £22,000 a year ago. Acquisition of other intangible assets was £5,000 against £143,000 a year ago.